Ann Keen: The details of each trust's deep clean plan will vary according to local need and the configuration of local services. All trusts were required to submit and agree their deep clean plans with primary care trusts in their area and this process has been monitored and assessed by strategic health authorities.
Ann Keen: Not all claims related to health care associated infection (HCAI) can be identified. The following table shows those claims where methicillin-resistant Staphylococcus aureus (MRSA) and/or Clostridium difficile ( C. difficile) are regarded as one of the injuries.
|Claims closed with no damages
|Claims settled with damages
|(1) Denotes data to date for current period.
NHS Litigation Authority.
Mr. Lansley: To ask the Secretary of State for Health how many cases of healthcare associated infections were voluntarily reported to the Healthcare Protection Agency in each of the last five financial years for which figures are available, broken down by (a) type of infection and (b) trust. 
Ann Keen: The following table gives data collected from the voluntary reporting system from 2002 to 2006 for the nine most common causes of bacteraemia (bacterial bloodstream infections) and for Clostridium difficile (C. difficile), which is associated with diarrhoea and not the blood stream. These data are not available by trust or by financial year.
Healthcare Protection Agency laboratory reports (voluntary reporting system).
The increase in bacteraemias is partly due to better reporting, surveillance and testing and may also reflect a changing hospital population, with more patients who are vulnerable to infection through conditions which compromise their immune systems being treated.
Mr. Todd: To ask the Secretary of State for Health how many responses have been received to the consultation on Arrangements under Part IX of the Drug Tariff for the provision of stoma and incontinence appliances; and if he will make a statement. 
Dawn Primarolo: The Department has received 140 responses to the consultation on Arrangements under part IX of the Drug Tariff for the provision of stoma and incontinence appliancesand related servicesto Primary Care which closed on 28 December 2007.
Anne Milton: To ask the Secretary of State for Health whether the South West Surrey and Hampshire Cancer Network recommends Dasatinib for the treatment of imatinib-resistant chronic myeloid leukaemia. 
Ann Keen: Dasatinib has been licensed for the treatment of chronic myeloid leukaemia (CML) with resistance or intolerance to imatinib mesylate. The National Institute for Health and Clinical Excellence (NICE) has not yet published guidance on the use of Dasatinib. Until NICE guidance is published, it is for primary care trusts (PCTs) to make decisions based on the evidence that is available on whether to fund drugs locally.
South East Coast strategic health authority has advised officials that Surrey, West Sussex and Hampshire Cancer Network has not produced any formal recommendations on the use of Dasatinib. It does, however, provide advice and recommendations to PCTs on an individual patient basis when requested to do so.
Mr. Lansley: To ask the Secretary of State for Health pursuant to the answer of 13 December 2007, Official Report, column 875W, on maternity services, which trusts provided maternity services in each of the five years before 2005-06. 
Ann Keen: We do not collect this information centrally. However, data for 2004-05 are in NHS Maternity Statistics, England: 2004-05 copies of which are available in the Library. Copies of the 2002-03, 2001-02 reports are also available in the Library.
To ask the Secretary of State for Health pursuant to the oral answer to the hon. Member for Nuneaton (Mr. Olner) of 5 February 2008, Official
Report, column 784, on maternity services, what the evidential basis is for his statement that the UK is the safest country in the world in which to deliver babies. 
Ann Keen [holding answer 18 February 2008]: The United Kingdom is one of the safest countries in the world in which to deliver babies. The Confidential Enquiry into Maternal and Child Health's publication, Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer2003-2005 published in December 2007 (copies of which have been placed in the Library) indicated that there were just under seven maternal deaths per 100,000 live births in the UK in the three years to 2005. The UK is very near to the top in any league table, with much lower death rates than the United States or France.
Mr. Lansley: To ask the Secretary of State for Health pursuant to paragraph 2.50 of the NHS in Englands Operating Framework for 2008-09, how his Department defines sufficient numbers of maternity staff and neo-natal teams to meet local needs in terms of (a) the population of a primary care trust and (b) the number of births at a maternity unit. 
Ann Keen: It is for primary care trusts and national health service trusts to decide locally how to use their resources to provide services for the people for whom they are responsible, in line with the NHS Operating Framework. Staffing levels in maternity services vary throughout the country and are dependent on a range of factors including model of care and skill mix such as the use of maternity support workers.
Mr. Gale: To ask the Secretary of State for Health what estimate he has made of the percentage of NHS correspondence and typing of health service records of consultations that were sent to the Indian sub-continent for processing in the most recent period for which figures are available. 
Mr. Bradshaw [holding answer 18 February 2008]: The effective management of patient records is the responsibility of the individual NHS organisation that creates them. Information is not held centrally on the number of national health service organisations that currently outsource aspects of patient record management, including the typing of patient records, to the Indian sub-continent. It is therefore not possible to make such an estimate.
Mark Simmonds: To ask the Secretary of State for Health whether his Department issues guidance to health care professionals on the involvement of patients in decisions on changing their medicinal regimes. 
While the Department has not issued guidance itself, the establishment of Medicines Partnership promotes the concept of concordanceor shared decision makingto help patients take their medicines better and to help them get the most from their medicines. Medicines partnership has, over the years, worked both with professionals and members of the public to promote shared decision making.
The Department also supports Ask About Medicines Week, which continues to develop initiatives to empower members of the public to ask questions of health care professionals about the medicines prescribed for them and be involved in the decisions about the medicines prescribed for them.